Home

Search results

Technology(Page)
rate to assure a tightly controlled release of the active substance, providing a better therapeutic effect in situ and causing lower systemic...

Delivery solutions for biological macromolecus(Page)
Controlled release of biological macromolecules With DelSiTech's silica matrix you can administer peptides, proteins, RNA, DNA and complex car...

Supergeneric drug developmet(Page)
the market potential of a controlled release competitor product.Furthermore, the silica-based controlled release product should provide signif...

Business Strategy(Page)
significant player in the controlled release supergeneric product markets with a first-in-class market leader product for sale in the major gl...

Services(Page)
ation of the silica-based controlled release products, and we can give you our expert opinion on the technology suitability to their purposes ...

DelSiTech Ltd enters licensing agreement with Solani Therapeutics Ltd in animal health(News)
tion development space of controlled release veterinary drugs. Finnish drug delivery and development Company DelSiTech Ltd announced today...

Technology applications(Page)
to administer parenteral controlled release drugs more precisely, safely and cost-effectively than with other alternative drug delivery techn...

DelSiTech Ltd starts new collaboration projects with two Animal Health companies(News)
no, CEO of DelSiTech Ltd.“Controlled release drug products are especially well suited for treatment of animals which are often difficult to tr...

Home(Page)
iodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals and viral vectors. We focus on parenteral and local a...